Cargando…

Traditional Chinese Medicine Containing Arsenic Treated MDS Patients Effectively through Regulating Aberrant Hypomethylation

Aberrant hypermethylation and hypomethylation both play important roles in myelodysplastic syndrome (MDS). Hypomethylating agents targeting hypermethylation have been employed for the MDS treatment, but the treatment effect is limited. Novel drugs for DNA hypomethylation-targeted therapy may be need...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Qing-bing, Zhu, Qian-zhe, Wang, Hong-zhi, Wang, De-xiu, Liu, Zheng-tang, Xu, Yong-gang, Hu, Xiao-mei, Ma, Rou, Xu, Feng-qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085376/ https://www.ncbi.nlm.nih.gov/pubmed/32215045 http://dx.doi.org/10.1155/2020/7469809

Ejemplares similares

Karyotype and DNA-Methylation Responses in Myelodysplastic Syndromes following Treatment with Traditional Chinese Formula Containing Arsenic
por: Shuzhen, Sun, et al.
Publicado: (2012)

Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome
por: Zhou, Qing-Bing, et al.
Publicado: (2020)

Comparison of Hypomethylator Monotherapy with Hypomethylator plus Chemotherapy for Intermediate/High-Risk MDS or AML: A Meta-Analysis
por: Ji, Jiang, et al.
Publicado: (2020)

Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents
por: Livio, Pagano, et al.
Publicado: (2018)

Clinical Response to Traditional Chinese Herbs Containing Realgar (As(2)S(2)) is Related to DNA Methylation Patterns in Bone Marrow DNA from Patients with Myelodysplastic Syndrome with Multilineage Dysplasia
por: Zhou, Qing-Bing, et al.
Publicado: (2021)

Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML
por: Kubasch, Anne Sophie, et al.
Publicado: (2018)

Arsenic and Mercury Containing Traditional Chinese Medicine (Realgar and Cinnabar) Strongly Inhibit Organic Anion Transporters, Oat1 and Oat3, In Vivo in Mice
por: Yu, Wen-Hao, et al.
Publicado: (2015)

Identification of radiation-induced aberrant hypomethylation in colon cancer
por: Bae, Jin-Han, et al.
Publicado: (2015)

Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy
por: Poon, Zhiyong, et al.
Publicado: (2018)

Increased separase activity and occurrence of centrosome aberrations concur with transformation of MDS
por: Ruppenthal, Sabrina, et al.
Publicado: (2018)

Arsenic Bioaccessibility of Realgar Influenced by the Other Traditional Chinese Medicines in Niuhuang Jiedu Tablet and the Roles of Gut Microbiota
por: Xu, Wenfeng, et al.
Publicado: (2019)

Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?
por: Upchurch, Garland Michael, et al.
Publicado: (2016)

Aberrant Expression of TET2 Accounts for DNA Hypomethylation in Varicocele
por: Taghian Dinani, Hengameh, et al.
Publicado: (2023)

Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker
por: Sung, Hye Youn, et al.
Publicado: (2018)

Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts
por: Yahng, Seung-Ah, et al.
Publicado: (2016)

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents
por: Duchmann, M, et al.
Publicado: (2017)

Correction: Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy
por: Poon, Zhiyong, et al.
Publicado: (2019)

Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines
por: Qiu, Chong, et al.
Publicado: (2023)

Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming
por: Xiong, Lei, et al.
Publicado: (2019)

ETCM: an encyclopaedia of traditional Chinese medicine
por: Xu, Hai-Yu, et al.
Publicado: (2019)

TREATMENT OF PHARYNGEAL DIPHTHERIA AND PHARYNGITIS WITH TRADITIONAL CHINESE MEDICINE
por: Zhang, Shi Xiu, et al.
Publicado: (1984)

Potential Mechanisms of Aberrant DNA Hypomethylation on the X Chromosome in Uterine Leiomyomas
por: SATO, Shun, et al.
Publicado: (2013)

Aberrant DNA hypomethylation of miR-196b contributes to migration and invasion of oral cancer
por: HOU, YU-YI, et al.
Publicado: (2016)

Chromosome aberrations in workers exposed to arsenic.
por: Beckman, G, et al.
Publicado: (1977)

P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS-IBI)
por: Runzhi, MA, et al.
Publicado: (2023)

Evaluation of different scoring systems and gene mutations for the prognosis of myelodysplastic syndrome (MDS) in Chinese population
por: Du, Meng-yi, et al.
Publicado: (2020)

Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN
por: Mestrum, Stefan G. C., et al.
Publicado: (2020)

Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation
por: Ørskov, Andreas D., et al.
Publicado: (2015)

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents
por: Short, Nicholas J., et al.
Publicado: (2023)

Therapeutic potential of traditional Chinese medicine on heat stroke
por: Li, Lei, et al.
Publicado: (2023)

Hemolytic Anemia as a Sequela of Arsenic Intoxication Following Long-Term Ingestion of Traditional Chinese Medicine
por: Lee, Je-Jung, et al.
Publicado: (2004)

Traditional Chinese medicine for knee osteoarthritis: An overview of systematic review
por: Yang, Min, et al.
Publicado: (2017)

Aberrant hypomethylation at imprinted differentially methylated regions is involved in biparental placental mesenchymal dysplasia
por: Aoki, Saori, et al.
Publicado: (2022)

Somatic mutations in SF3B1 aberrant‐negative MDS‐RS most commonly involved in TP53 genes
por: Li, Xiao, et al.
Publicado: (2022)

P706: RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISKMYELODYSPLASTIC SYNDROME (HR-MDS): THE ROLE OF THE ADENOSINEDEAMINASE ACTING ON RNA 1 (ADAR1) ENZYME
por: Dimitriou, Despoina, et al.
Publicado: (2023)

Traditional Chinese Medicine for Senile Dementia
por: Lin, Zhihong, et al.
Publicado: (2012)

Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors
por: Xu, Qing-Yu, et al.
Publicado: (2020)

Chronic exposure to arsenic, LINE-1 hypomethylation, and blood pressure: a cross-sectional study in Bangladesh
por: Hossain, Khaled, et al.
Publicado: (2017)

Arsenic as Traditional Chinese Medicine Provides New Hope for Overcoming High Treatment Costs of Acute Promyelocytic Leukemia
por: Zhu, Hong-Hu, et al.
Publicado: (2016)

Chromium-Containing Traditional Chinese Medicine, Tianmai Xiaoke Tablet, for Newly Diagnosed Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review of Randomized Clinical Trials
por: Gu, Yuming, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e9e5nmmiju1abhmtko0c6n6ikg